Latest Stories
Q3 Earnings Outperformers: Shoe Carnival (NASDAQ:SCVL) And The Rest Of The Apparel and Footwear Retail Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Shoe Carnival (NASDAQ:SCVL) and the rest of the apparel and footwear retail stocks fared in Q3.
Construction and Maintenance Services Stocks Q3 Recap: Benchmarking Limbach (NASDAQ:LMB)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at construction and maintenance services stocks, starting with Limbach (NASDAQ:LMB).
Life Insurance Stocks Q3 Recap: Benchmarking Brighthouse Financial (NASDAQ:BHF)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life insurance industry, including Brighthouse Financial (NASDAQ:BHF) and its peers.
Earnings To Watch: BNY (BK) Reports Q4 Results Tomorrow
Global financial services company BNY NYSE:BK) will be reporting results this Tuesday before market hours. Here’s what you need to know.
Delta (DAL) Reports Earnings Tomorrow: What To Expect
Global airline Delta Air Lines (NYSE:DAL) will be reporting results this Tuesday morning. Here’s what you need to know.
JPMorgan Chase (JPM) Q4 Earnings Report Preview: What To Look For
Global financial services giant JPMorgan Chase (NYSE:JPM) will be reporting earnings this Tuesday before market open. Here’s what to expect.
Concrete Pumping (BBCP) Q3 Earnings: What To Expect
Concrete and waste management company Concrete Pumping (NASDAQ:BBCP) will be reporting earnings this Tuesday after market hours. Here’s what to look for.
Concentrix (CNXC) Q4 Earnings Report Preview: What To Look For
Customer experience solutions provider Concentrix (NASDAQ:CNXC) will be reporting results this Tuesday before the bell. Here’s what to expect.
2 Cash-Heavy Stocks to Keep an Eye On and 1 We Question
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
What a brutal six months it’s been for CONMED. The stock has dropped 20.6% and now trades at $42.52, rattling many shareholders. This may have investors wondering how to approach the situation.